100 VANGUARD BOULEVARD,
MALVERN , PA, 19355
MALVERN , PA, 19355
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
The process employs an indexing investment approach to track the performance More
Webiste
Directors
Nov 14, 2023- Tara Bunch
- Emerson U. Fullwood
- Grant Reid
- David Thomas
- Peter F. Volanakis
- F. Joseph Loughrey
- Mortimer J. Buckley
- Deanna Mulligan
- Andre F. Perold
- Sarah Bloom Raskin
- Mark Loughridge
- Scott C. Malpass
Chief Compliance Officer
- Jacqueline Angell
Price
- $ 270.77 ( -0.37 )
-
Jan 31, 2025Last Close
- Net Assets
-
$18.7B
Jan 29, 2024
- 52-Week High/Low
- $288.1 - $250.8
- Expense Ratio
- -
Performance
YTD
0%
3 Year
10.37%
5 Year
44.84%
Best
42.68%
2013
Worst
-23.34%
2008
Company Name |
Holding |
| Eli Lilly & Co | 11.73 % |
| UnitedHealth Group Inc | 8.23 % |
| AbbVie Inc | 4.77 % |
| Johnson & Johnson | 4.58 % |
| Merck & Co Inc | 3.8 % |
| Thermo Fisher Scientific Inc | 3.55 % |
| Abbott Laboratories | 2.97 % |
| Danaher Corp | 2.87 % |
| Amgen Inc | 2.71 % |
| Intuitive Surgical Inc | 2.64 % |
| More | 2.64 % |
Documents
NAV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VHT | 0% | 3.3% | 1.1% | -6.3% | 19.8% | 15.3% | 20.2% | 5.6% | 23.3% | -3.2% | |
| S&P 500 | 2.7% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| q1 | 0% | 7.9% | -3.9% | -3.9% | 2.2% | -13.4% | 8.1% | -0.2% | 9.1% | -6.9% | ||||
| q2 | 0% | -2.4% | 2.7% | -7.4% | 9.4% | 16% | 0.2% | 6.7% | 7.3% | 6.2% | ||||
| q3 | 0% | 0% | -4% | -5% | 0% | 4.9% | -4.4% | 13.2% | 3.7% | 2.2% | ||||
| q4 | 0% | 0% | 7% | 10.9% | 7.8% | 9.4% | 14.7% | -10.9% | 0.5% | -4.2% |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 2024 | 2.4% | 3.4% | 1.9% | -5.4% | 1.1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |